SCHEMBL18187464

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL21441513	1.00	ATM (0.69)	ATMMMP2ANPEPACEREN
	SCHEMBL18187482	1.00	ATM (0.69)	ATMMMP2ANPEPACEREN
	SCHEMBL28485257	1.00	ATM (0.69)	ATMMMP2ANPEPACEREN
	SCHEMBL18187463	1.00	ATM (0.69)	ATMMMP2ANPEPACEREN
	SCHEMBL1250894	0.83	ATM (0.47)	ATMACEREN
	SCHEMBL28531386	0.83	ATM (0.47)	ATMACEREN
	SCHEMBL1250892	0.83	ATM (0.47)	ATMACEREN
	SCHEMBL1250891	0.83	ATM (0.47)	ATMACEREN
	Oxaceprol SCHEMBL25978	0.82	ATM (1.00)	ATMMMP2ANPEPACE
	Oxaceprol SCHEMBL25977	0.82	ATM (1.00)	ATMMMP2ANPEPACE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.